MPP Strikes Long-Acting Injectable Cabotegravir Deal For HIV PrEP
Prospective Sub-Licensees Have Until 4 September To Submit Expressions Of Interest
After the Medicines Patent Pool secured a licensing deal with ViiV Healthcare for long-acting injectable cabotegravir for HIV pre-exposure prophylaxis, prospective generic sub-licensees have until 4 September to submit expressions of interest.
